Dr. Matthew David Kretschmar , MD
Internal Medicine β’ Omaha, NE
982055 Nebraska Medical Ctr
Omaha, NE 681982055
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Matthew Kretschmar is listed in NPPES under Internal Medicine.
-
NPI assigned on June 25, 2022; this date does not establish years in practice.
-
Published CMS data list 503 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium β 56 prescription fills, including refills.
- Albuterol Sulfate Hfa (Albuterol Sulfate) β 49 prescription fills, including refills.
- Amlodipine Besylate β 35 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 24 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Internal Medicine in Omaha, NE (2024, 268 clinicians with data). Median for this group: 302. Middle half: 82 to 2,563.
Close to the middle for Part D prescriptions among clinicians listed under Internal Medicine in Nebraska (2024, 421 clinicians with data). Median for this group: 346. Middle half: 77 to 4,377.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 400 in 2023 to 503 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2023β2024.
Practice Location & Contact Primary Location
982055 Nebraska Medical Ctr
Omaha, NE 681982055
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
835 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$64,411 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $14.86 in 2025
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2025.
NPI first issued
2022
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Kretschmar has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Kretschmar as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Omaha and Nebraska
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Internal Medicine in Omaha, NE (2024, 268 clinicians with data). Median for this group: 302. Middle half: 82 to 2,563.
Close to the middle for clinicians listed under Internal Medicine in Nebraska (2024, 421 clinicians with data). Median for this group: 346. Middle half: 77 to 4,377.
Part D drug cost
Close to the middle for clinicians listed under Internal Medicine in Omaha, NE (2024, 268 clinicians with data). Median for this group: $27,559. Middle half: $2,628 to $280,388.
Close to the middle for clinicians listed under Internal Medicine in Nebraska (2024, 421 clinicians with data). Median for this group: $35,458. Middle half: $2,601 to $360,630.
576 active clinicians are listed under Internal Medicine with a practice address in Omaha, NE (799 in Nebraska).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Omaha
10.6% of these 576 clinicians have the CMS telehealth indicator.
42.2% of these 576 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 26% from 400 in 2023 to 503 in 2024.
- 2023: 400
- 2024: 503
-
30-day fills
30-day fills increased 28% from 655 in 2023 to 835 in 2024.
- 2023: 655
- 2024: 835
-
Part D drug cost
Part D drug cost decreased 12% from $72,823 in 2023 to $64,411 in 2024.
- 2023: $72,823
- 2024: $64,411
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2025 only.
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): fewer than 11 records totaling $14.86.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Ambu Inc. |
Food and Beverage
Cash or cash equivalent
|
β | General | $14.86 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 56 | 3,121 | $444.96 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 973 | $660.75 | β |
| Amlodipine Besylate | Amlodipine Besylate | 35 | 2,159 | $193.41 | β |
| Pantoprazole Sodium | Pantoprazole Sodium | 31 | 1,080 | $77.63 | β |
| Metoprolol Succinate | Metoprolol Succinate | 22 | 1,015 | $176.49 | β |
| Lisinopril | Lisinopril | 21 | 1,084 | $76.45 | β |
| Gabapentin | Gabapentin | 20 | 1,538 | $369.03 | β |
| Losartan Potassium | Losartan Potassium | 19 | 877 | $61.67 | β |
| Trulicity | Dulaglutide | 19 | 532 | $18,690.23 | β |
| Hydrochlorothiazide | Hydrochlorothiazide | 18 | 628 | $74.95 | β |
| Ozempic | Semaglutide | 18 | 660 | $21,964.81 | β |
| Sertraline Hcl | Sertraline Hcl | 17 | 1,230 | $57.04 | β |
| Fluticasone Propionate | Fluticasone Propionate | 17 | 495 | $202.27 | β |
| Spironolactone | Spironolactone | 17 | 564 | $82.16 | β |
| Jardiance | Empagliflozin | 17 | 456 | $9,151.36 | β |
| Omeprazole | Omeprazole | 16 | 1,192 | $539.58 | β |
| Ventolin Hfa | Albuterol Sulfate | 16 | 429 | $1,016.93 | β |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | 780 | $5,494.04 | β |
| Carvedilol | Carvedilol | 15 | 823 | $79.14 | β |
| Furosemide | Furosemide | 15 | 796 | $37.81 | β |
| Entresto | Sacubitril/Valsartan | 14 | 196 | $4,801.95 | β |
| Montelukast Sodium | Montelukast Sodium | 12 | 1,080 | $65.01 | β |
| Trazodone Hcl | Trazodone Hcl | 12 | 660 | $44.79 | β |
| Levothyroxine Sodium | Levothyroxine Sodium | 11 | 838 | $48.95 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-06-25NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSORDER AND REFERRING ONLY - PULMONARY DISEASE
I20221102002652
NE
8921475047
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Student in an Organized Health Care Education/Training Program
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Student in an Organized Health Care Education/Training Program
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Career & Practice History
NPI enumerated June 25, 2022.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from July 2022 to November 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Omaha
- Dr. Kenneth Mueller, MD
- Dr. Amy Coffey, MD
- Dr. Mostafa Elgayesh, MD
- Dr. Mark Oberlies, MD
- Dr. Tanvir Hussain, MD, MSC
- Dr. Elizabeth Denman, MD
Mailing Address
982055 Nebraska Medical Ctr
Omaha, NE 681982055
Phone: 4025597738